Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Beclomethasone dipropionate [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 400 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 400 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg inhalator + kompakt spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg kompakt spacer til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 400 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg blisterplader + diskhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg blisterplader til genopfyldning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 100 microgram/actuation pressurized solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate [respiratory use 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 250 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionatpræparat opløsning til nasal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone diprop [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 0,042 % spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 42mcg inhaler (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 42mcg/act |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 84mcg/spray spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 42 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 8.4mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclometasone dipropionate 84 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 400 µg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 80 µg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 42 µg inhalationsaerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate nasal preparation |
Is a |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 400micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg + salbutamol 400 µg inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg + salbutamol 200 µg pædiatrisk inhalationspulver, kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg + salbutamol 100 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclomethasone dipropionate+salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 400 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 200 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 50 µg CFC-fri indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg CFC-fri inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 100 µg CFC-fri indåndingsudløst aerosolinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclometasone dipropionate monohydrate (substance) |
Is a |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
beclometasondipropionat 84 µg inhalationsaerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclometasone dipropionate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclometasone dipropionate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
|
Beclometasone dipropionate 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 50 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 50 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 100 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 200 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 200 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 100 microgram/actuation pressurized solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 100 microgram/actuation pressurized solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 200 microgram/actuation pressurized solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 200 microgram/actuation pressurized solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 250 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 250 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 250 microgram/actuation pressurized solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 250 microgram/actuation pressurized solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 400 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 400 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 50 microgram/actuation pressurized solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclomethasone dipropionate 50 microgram/actuation pressurized solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 50 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 50 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 84 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 84 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
1 |
Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
2 |
Beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
2 |
Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
2 |
Beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
2 |
Beclometasone dipropionate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Beclometasone dipropionate |
Inferred relationship |
Some |
|